Sort by

Send to

Choose Destination

Links from PubMed

Items: 9


Modeling of rifampicin-induced CYP3A4 activation dynamics for the prediction of clinical drug-drug interactions from in vitro data.

Yamashita F, Sasa Y, Yoshida S, Hisaka A, Asai Y, Kitano H, Hashida M, Suzuki H.

PLoS One. 2013 Sep 24;8(9):e70330. doi: 10.1371/journal.pone.0070330. eCollection 2013.


Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature.

Martins MA, Reis AM, Sales MF, Nobre V, Ribeiro DD, Rocha MO, Ribeiro AL.

BMC Pharmacol Toxicol. 2013 May 4;14:27. doi: 10.1186/2050-6511-14-27. Review.


Pharmacokinetics of ethionamide in children.

Thee S, Seifart HI, Rosenkranz B, Hesseling AC, Magdorf K, Donald PR, Schaaf HS.

Antimicrob Agents Chemother. 2011 Oct;55(10):4594-600. doi: 10.1128/AAC.00379-11. Epub 2011 Jul 25.


Effect of single-dose rifampin on the pharmacokinetics of warfarin in healthy volunteers.

Frymoyer A, Shugarts S, Browne M, Wu AH, Frassetto L, Benet LZ.

Clin Pharmacol Ther. 2010 Oct;88(4):540-7. doi: 10.1038/clpt.2010.142. Epub 2010 Aug 11.


The transcriptional regulation of the human CYP2C genes.

Chen Y, Goldstein JA.

Curr Drug Metab. 2009 Jul;10(6):567-78. Epub 2009 Jul 15. Review.


Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes.

Glaeser H, Drescher S, Eichelbaum M, Fromm MF.

Br J Clin Pharmacol. 2005 Feb;59(2):199-206.


Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects.

Niemi M, Backman JT, Neuvonen M, Neuvonen PJ.

Br J Clin Pharmacol. 2003 Oct;56(4):427-32.


Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride.

Niemi M, Kivistö KT, Backman JT, Neuvonen PJ.

Br J Clin Pharmacol. 2000 Dec;50(6):591-5.


Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.

Miners JO, Birkett DJ.

Br J Clin Pharmacol. 1998 Jun;45(6):525-38. Review.

Items per page

Supplemental Content

Write to the Help Desk